# A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

> **NCT05330325** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 412 (actual)

## Conditions studied

- SGA, Turner Syndrome, Noonan Syndrome, ISS

## Interventions

- **DRUG:** Somapacitan
- **DRUG:** Norditropin®

## Key facts

- **NCT ID:** NCT05330325
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-10
- **Primary completion:** 2024-08-05
- **Final completion:** 2027-10-29
- **Target enrollment:** 412 (ACTUAL)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05330325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05330325, "A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05330325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*